WEBULL
News
ETON
14.81
+0.34%
0.05
Weekly Report: what happened at ETON last week (0202-0206)?
Weekly Report · 20h ago
Analysts Are Bullish on These Healthcare Stocks: Eton Pharmaceuticals (ETON), HealthStream (HSTM)
TipRanks · 02/02 14:20
Eton Pharmaceuticals Licenses U.S. Rights to Ultra-Rare Drug
TipRanks · 02/02 12:39
Eton licenses U.S. marketing rights to ultra-rare disease product candidate
TipRanks · 02/02 11:55
Eton Pharmaceuticals Plans 2026 Launch of FDA-Reviewed Ultra-Rare Disease Product, Expands Pipeline and Pursues Additional High-Value Opportunities
Reuters · 02/02 11:55
Eton Pharma Announces Licensing Of U.S. Marketing Rights To Ultra-Rare Disease Product Candidate; Product Is Currently Under Review With FDA; Potential Approval And Launch Mid-2026
Benzinga · 02/02 11:51
ETON PHARMACEUTICALS INC - POTENTIAL APPROVAL AND LAUNCH MID-2026
Reuters · 02/02 11:50
Weekly Report: what happened at ETON last week (0126-0130)?
Weekly Report · 02/02 09:05
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
Barchart · 02/02 05:50
Biotech Stocks Facing FDA Decision In February 2026
NASDAQ · 01/28 03:44
Weekly Report: what happened at ETON last week (0119-0123)?
Weekly Report · 01/26 09:05
Eton Pharmaceuticals: An Undervalued Small Cap With High Growth
Seeking Alpha · 01/23 15:20
Weekly Report: what happened at ETON last week (0112-0116)?
Weekly Report · 01/19 09:05
Weekly Report: what happened at ETON last week (0105-0109)?
Weekly Report · 01/12 09:05
Weekly Report: what happened at ETON last week (1229-0102)?
Weekly Report · 01/05 09:05
Weekly Report: what happened at ETON last week (1222-1226)?
Weekly Report · 12/29/2025 09:05
Weekly Report: what happened at ETON last week (1215-1219)?
Weekly Report · 12/22/2025 09:05
Analysts’ Top Healthcare Picks: Foghorn Therapeutics (FHTX), Eton Pharmaceuticals (ETON)
TipRanks · 12/17/2025 13:30
Weekly Report: what happened at ETON last week (1208-1212)?
Weekly Report · 12/15/2025 09:05
More
Webull provides a variety of real-time ETON stock news. You can receive the latest news about Eton Pharmaceuticals through multiple platforms. This information may help you make smarter investment decisions.
About ETON
Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company has six commercial rare disease products: INCRELEX, ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. INCRELEX is a biologic product used to treat pediatric patients 2 years of age and older who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD). ALKINDI SPRINKLE is for the treatment of pediatric adrenocortical insufficiency. Carglumic Acid is for the treatment of hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. Betaine Anhydrous is for the treatment of homocystinuria. Nitisinone is for the treatment of hereditary tyrosinemia type 1 (HT-1). PKU GOLIKE is a medical formula for patients with phenylketonuria (PKU). Galzin, its product, is FDA-approved for the treatment of the ultra-rare metabolic condition of Wilson Disease.